• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of May 15, 2024

    FDA

    Enforcement Report - Week of December 7, 2022

    FDA

    Enforcement Report - Week of November 30, 2022

    FDA

    Enforcement Report - Week of June 2, 2021

    FDA

    Acella, facing 43 `serious` side effect reports, pulls dozens of lots

    FIERCEPHARMA

    Acella Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid®

    PRNEWSWIRE

    Acella Pharmaceuticals, LLC Issues Recall NP Thyroid®15 & 120 Due to Sub Potency

    FDA

    Quality Lowdown: Warning Letters Suggest How FDA Set Priorities During COVID-19

    PINK SHEET

    Acella Pharmaceuticals Receives FDA Warning Letter

    FDA

    FDA warns Mylan, Acella Pharmaceuticals over GMP violations

    RAPS

    Enforcement Report - Week of June 10, 2020

    FDA

    Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid®

    FDA

    Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection

    PR NEWSWIRE

    Acella Pharmaceuticals, LLC, announces approval of generic to Vituz®

    PR NEWSWIRE

    Acella Pharms `s Generic Chlorpheniramine Maleate; Hydrocodone Bitartrate Receives Approval In US

    FDA

    Acella Pharms Llc Generic Brompheniramine Maleate; Dextromethorphan Hydrobromide; Pseudoephedrine Hydrochloride Approved In U.S

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.